5th Circuit blocks mail delivery of common abortion pill, forcing in-person distribution nationwide

A unanimous ruling by the 5th U.S. Circuit Court blocks mailing mifepristone prescriptions and requires in-person distribution at clinics, overruling FDA rules. The decision applies nationwide while the case continues and could be appealed to the Supreme Court, signaling a major shift in how telemedicine and out-of-state prescriptions for abortion pills are treated and prompting ongoing legal and political battles in states with shield laws.